Ketamine subcutaneous(Bexson Biomedical)

N/A

Report date: 2025/10/29 11:43:26

Base Information

Drug NameKetamine subcutaneous(Bexson Biomedical)
Drug Alias NameBB106BB-106
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBexson Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesBexson Biomedical Inc
Inactive CompaniesN/A
Active IndicationsPain, Postoperative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A